By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oculus Innovative Sciences, Inc. 

1135 North McDowell Boulevard

Petaluma  California  94954  U.S.A.
Phone: 707-782-0792 Fax: 707-782-0705


SEARCH JOBS

Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures, and markets a family of Microcyn® Technology-based products intended to help prevent and treat infections in chronic and acute wounds. Oculus’ platform technology, called Microcyn, is a non-irritating proprietary oxychlorine formulation designed to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores.

Oculus’ principal operations are in Petaluma, California, and it conducts operations in Europe and Latin America through its wholly-owned subsidiaries, Oculus Innovative Sciences Netherlands B.V. and Oculus Technologies of Mexico, S.A. de C.V.

Last Updated: 05-23-2007

Key Statistics


Email: hr@oculusis.com
Ownership: Public

Web Site: Oculus Innovative Sciences
Employees:
Symbol: OCLS
 









Company News
Oculus Innovative Sciences (OCLS) Grabs FDA Approval for Lasercyn 4/20/2016 6:01:34 AM
Oculus Innovative Sciences, Inc. (OCLS) Reports Third Quarter Financial Results 2/5/2016 7:38:12 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Fiscal Third Quarter 2016 Financial Results And Conference Call 1/21/2016 7:45:14 AM
Oculus Innovative Sciences, Inc. (OCLS) Wins CE Mark for New MucoClyns for First Responders 1/14/2016 6:02:47 AM
Oculus Innovative Sciences, Inc. (OCLS) Introduces Microcynah Next-Generation Dermatology Products With Dimethicone For Animals 9/24/2015 8:15:18 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Preliminary Results For Its 2015 Annual Meeting Of Stockholders 9/14/2015 6:55:30 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Introduction Of Alevicyn SG Antipruritic Spray Gel For Relief Of Pain And Itch In Atopic Dermatitis 8/19/2015 8:08:18 AM
Oculus Innovative Sciences, Inc. (OCLS) Reports Financial Results For The First Quarter Of Fiscal Year 2016 7/31/2015 7:46:34 AM
Oculus Innovative Sciences, Inc. (OCLS) Announces Fiscal First Quarter 2016 Financial Results And Conference Call 7/16/2015 7:49:31 AM
Oculus Innovative Sciences, Inc. (OCLS) Receives New U.S. Patent For Microcyn Technology In Treatment Of Atopic Dermatitis 7/8/2015 7:19:37 AM
12345678910...
//-->